Morepen Laboratories Share Price
₹79.89 -3.36 (-4.04%)
22 Dec, 2024 21:57
Start SIP in MOREPENLAB
Start SIPPerformance
- Low
- ₹79
- High
- ₹85
- 52 Week Low
- ₹39
- 52 Week High
- ₹101
- Open Price₹84
- Previous Close₹83
- Volume5,427,778
Investment Returns
- Over 1 Month + 9.09%
- Over 3 Month -7.49%
- Over 6 Month + 48.38%
- Over 1 Year + 65.4%
Smart Investing Starts Here Start SIP with Morepen Laboratories for Steady Growth!
Morepen Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 33.3
- PEG Ratio
- 0.2
- Market Cap Cr
- 4,378
- P/B Ratio
- 5.2
- Average True Range
- 3.4
- EPS
- 2.4
- Dividend Yield
- 0
- MACD Signal
- 1.44
- RSI
- 41.42
- MFI
- 70.15
Morepen Laboratories Financials
Morepen Laboratories Technicals
EMA & SMA
Current Price
₹79.89
-3.36
(-4.04%)
- Bullish Moving Average 4
- Bearish Moving Average 12
- 20 Day
- ₹83.61
- 50 Day
- ₹81.99
- 100 Day
- ₹77.67
- 200 Day
- ₹68.71
Resistance and Support
81.17
- R3 88.80
- R2 86.68
- R1 83.29
- S1 77.78
- S2 75.66
- S3 72.27
Morepen Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-21 | Audited Results | |
2024-01-31 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Morepen Laboratories F&O
About Morepen Laboratories
- NSE Symbol
- MOREPENLAB
- BSE Symbol
- 500288
- Chairman & Managing Director
- Mr. Sushil Suri
- ISIN
- INE083A01026
Similar Stocks to Morepen Laboratories
Morepen Laboratories FAQs
Morepen Laboratories share price is ₹79 As on 22 December, 2024 | 21:43
The Market Cap of Morepen Laboratories is ₹4377.6 Cr As on 22 December, 2024 | 21:43
The P/E ratio of Morepen Laboratories is 33.3 As on 22 December, 2024 | 21:43
The PB ratio of Morepen Laboratories is 5.2 As on 22 December, 2024 | 21:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.